AGN 195183

  • CAT Number: I003352
  • CAS Number: 367273-07-2
  • Molecular Formula: C22H22ClF2NO4
  • Molecular Weight: 437.86
  • Purity: ≥95%
Inquiry Now

AGN 195183 (Cat.No:I003352) (also known as Darapladib) is a potent inhibitor of Lp-PLA2, an enzyme involved in the formation of atherosclerotic plaques. It has been studied for its potential use in reducing cardiovascular risk in patients with coronary heart disease. AGN 195183 has shown promising results in clinical trials, but further research is needed.

Catalog Number I003352
CAS Number 367273-07-2
Molecular Formula

C22H22ClF2NO4

Purity 95%
Target RAR/RXR
Solubility 10 mM in DMSO
Storage Store at -20°C
IC50 3 nM (Kd); 200 nM (EC80, RAR Trans.)
IUPAC Name 4-[(4-chloro-3-hydroxy-5,5,8,8-tetramethyl-6,7-dihydronaphthalene-2-carbonyl)amino]-2,6-difluorobenzoic acid
InChI InChI=1S/C22H22ClF2NO4/c1-21(2)5-6-22(3,4)16-12(21)9-11(18(27)17(16)23)19(28)26-10-7-13(24)15(20(29)30)14(25)8-10/h7-9,27H,5-6H2,1-4H3,(H,26,28)(H,29,30)
InChIKey PNAWUIKCVQSLFG-UHFFFAOYSA-N
SMILES CC1(CCC(C2=C1C=C(C(=C2Cl)O)C(=O)NC3=CC(=C(C(=C3)F)C(=O)O)F)(C)C)C
Reference

<p style=/line-height:25px/>
<br>[1]. Beard RL, et al. Synthesis and biological activity of retinoic acid receptor-alpha specific amides. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3145-8.
</p>

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!